EvodiaBio ApS

Private limited companyCVR 42569283RødovreActive

EvodiaBio ApS is a private limited company, based in Rødovre, active in research and experimental development on natural sciences and engineering, founded in 2021. The company made a loss in both 2024 and 2025, most recently DKK 26.8m. With 23 employees, the company is about 5 times larger than the industry median. Equity grew to DKK 68.6m in 2025.

Follow
PDF reportCompare

Key figures · financial year 2025

Gross profit−DKK 8.4m+15.7% vs. 2024
Net profit−DKK 26.8m−27% vs. 2024
EquityDKK 68.6m+30.9% vs. 2024
Employees23latest month from CVR

What has changed

calculated from recorded figures and dates

Financials: 2025 against 2024

  • The loss grew: from DKK 21.1m to DKK 26.8m (2024 → 2025).
  • Equity rose 31% (2024 → 2025), to DKK 68.6m.

Employees

  • 6 fewer employees than a year earlier: 23 (07/2026) against 29 (07/2025).

Management and owners, last 24 months

  • New in management: Kyle Bjorn Teamey (board member, 09/12/2025).
  • Stepped down: Sotirios Kampranis (board member, 09/12/2025), Simon Louis Théodore Armand Dusséaux (director, 31/07/2025) and Lauri Johannes Reuter (board member, 09/12/2025).
  • New owners registered: Jarne Elleholm (17/12/2025), FormanBiotech Holding ApS (17/12/2025) and Starfish Bio ApS (17/12/2025) (+3).
  • No longer registered as owner: Jarne Elleholm (16/12/2025), FormanBiotech Holding ApS (16/12/2025) and Starfish Bio ApS (16/12/2025) (+4).

Registrations, last 24 months

  • 09/12/2025: Share capital changed from 99,802 DKK to 137,980 DKK
  • 01/01/2025: Industry changed to Research and experimental development on natural sciences and engineering (721000)

Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.

Financial statements

Financial years 2021–2025 · amounts in DKK thousand

Equity and net profit

−DKK 40m−DKK 20mDKK 0DKK 20mDKK 40mDKK 60m20212022202320242025
EquityNet profit
Financial figures for EvodiaBio ApS
20212022202320242025Change
Revenuenot statednot statednot statednot statednot stated–
Gross profit−608−2,943−9,942−10,009−8,437+15.7%
Operating profit (EBIT)−1,130−7,186−17,501−24,577−29,691−20.8%
Profit before tax−1,184−7,449−17,074−24,324−30,030−23.5%
Net profit−1,027−6,305−14,057−21,107−26,798−27%
Total assets3,80638,48728,16655,04389,335+62.3%
Equity−78737,68223,62652,42468,626+30.9%
Liabilities4,5928054,5402,61920,709+690.6%
Cash and cash equivalents3,51235,39811,20933,59951,675+53.8%
Average number of employees47101723+35.3%

Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2021, 2022, 2023, 2024, 2025: smaller companies may omit it, and we do not derive it from other figures.

Download the figures as CSV · free with an account, amounts in whole DKK

−DKK 12m−DKK 10m−DKK 8m−DKK 6m−DKK 4m−DKK 2mDKK 020212022202320242025
Gross profitMedian, the industry (431 companies)

Signals from the financial statements

calculated from the 2025 figures
  • Loss for 5 years in a row

    Net result has been negative in 2021–2025.

    How is this calculated?

    Net result is negative in the two or more latest annual reports in a row.

The signals are rules applied to the figures in the annual reports. They are not an assessment or credit rating of the company. See Data and method.

Annual reports

5 financial years
Annual reports for EvodiaBio ApS
Financial yearPeriodPublishedFigures forDocuments
202501/01/2025 – 31/12/202516/06/2026The companyPDF not statedXBRL
202401/01/2024 – 31/12/202427/05/2025The companyPDFXBRL
202301/01/2023 – 31/12/202323/05/2024The companyPDFXBRL
202201/01/2022 – 31/12/202217/05/2023The companyPDFXBRL
202128/07/2021 – 31/12/202129/06/2022The companyPDFXBRL

The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.

Employees

monthly figures from CVR
05101520253008/2309/2310/2311/2312/2301/2402/2403/2404/2405/2406/2407/2408/2409/2410/2411/2412/2401/2502/2503/2504/2505/2506/2507/2508/2509/2510/2511/2512/2501/2602/2603/2604/2605/2606/2607/26
Employees

Position in the industry

431 companies in the database

Comparison with the other companies in research and experimental development on natural sciences and engineering based on the latest financial year.

Gross profit−DKK 8.4mNo. 385 of 421
Better than 9% of the companies in the industry
EquityDKK 68.6mNo. 52 of 431
Better than 88% of the companies in the industry
Number of employees23No. 85 of 431
Better than 80% of the companies in the industry

Industry median: gross profit DKK 616k, net profit −DKK 892k, equity DKK 2m, 5 employees.

DKK 100kDKK 2.5mDKK 63.4mDKK 1.6bnDKK 13.7bn
Distribution of gross profit for 250 companies in the industry (latest financial year, logarithmic scale). Amber bar: where this company sits.

Compared with similar companies

size, age and company form
Rank among similar companies
GroupGross profitEquity
Companies with 20–49 employees9,922 companies in the comparison
No. 9,836of 9,892
Better than 1%
No. 526of 9,922
Better than 95%
Same industry and 20–49 employees64 companies in the comparison
No. 48of 62
Better than 23%
No. 19of 64
Better than 71%
Companies that are between 5 and 14 years old33,688 companies in the comparison
No. 33,487of 33,588
Better than 0%
No. 938of 33,687
Better than 97%
All companies of type ApS66,508 companies in the comparison
No. 66,268of 66,379
Better than 0%
No. 1,602of 66,505
Better than 98%

The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.

Compare with the industry

Research and experimental development on natural sciences and engineering
Gross profit
  1. EvodiaBio ApS−DKK 8.4m
  2. Carlsberg A/SDKK 40.2bn
  3. Zealand Pharma A/SDKK 9.2bn
Net profit
  1. EvodiaBio ApS−DKK 26.8m
  2. Carlsberg A/SDKK 7bn
  3. Zealand Pharma A/SDKK 6.5bn
Equity
  1. EvodiaBio ApSDKK 68.6m
  2. Carlsberg A/SDKK 30.7bn
  3. Zealand Pharma A/SDKK 14.8bn
Employees
  1. EvodiaBio ApS23
  2. Carlsberg A/S107
  3. Zealand Pharma A/S569

Latest financial year per company. Choose up to three companies from the largest in the industry.

Owners and group

from the Public Ownership Register
Owners
  • BII Holdings A/S5%
  • NFT.VC Fund I Ky5%
  • Jarne Elleholm5%
  • FormanBiotech Holding ApS5%
  • Starfish Bio ApS5%
  • Sdbio ApS5%
  • Danmarks Eksport- og Investeringsfond10%
  • RA Capital Planetary Health Fund, L.P.15%
EvodiaBio ApS

Management

7 active registrations

Executive management

Executive management at EvodiaBio ApS
NameRoleAppointed
Camilla Benedicte Kloss FennebergCEO15/11/2021

Board of directors

Board of directors at EvodiaBio ApS
NameRoleAppointed
Jarne ElleholmChair of the board28/07/2021
Flemming BesenbacherBoard member28/06/2022
Andreas Helmut FibigBoard member28/06/2022
Anne Françoise Véronique CabotinBoard member28/06/2022
Johan Bitsch NielsenBoard member17/05/2024
Kyle Bjorn TeameyBoard member09/12/2025
Founders
Leeward ApS, FormanBiotech Holding ApS, Starfish Bio ApS, Sdbio ApS
Former management (7)
Former management at EvodiaBio ApS
NameRoleAppointedResigned
Victor FormanBoard member28/07/202128/06/2022
Sotirios KampranisBoard member28/07/202109/12/2025
Simon Louis Théodore Armand DusséauxCEO28/07/202114/11/2021
Simon Louis Théodore Armand DusséauxBoard member28/07/202128/06/2022
Simon Louis Théodore Armand DusséauxDirector15/11/202131/07/2025
Lauri Johannes ReuterBoard member19/12/202209/12/2025
Bart Van HoolandBoard member19/12/202217/05/2024

Signing rule: Selskabet tegnes af bestyrelsesformanden og et bestyrelsesmedlem i forening, bestyrelsesformanden og et direktionsmedlem i forening, eller den samlede bestyrelse i forening.

Address and production units

1 active production units

Islevdalvej 211
2610 Rødovre

Rødovre Municipality · Postcode 2610

Production units
Production unitAddressEmployeesP number
EvodiaBio ApSIslevdalvej 211, 2610 Rødovre231027401941

Purpose

Selskabets formål er at udvikle nye aroma- og smagsstoffer til forskellige formål som inkluderer drikkevarer, fødevarer, parfume og andre anvendelser.

The purpose is quoted from the register in Danish.

Changes year by year

78 registered events
20261 changeaccounts 1
  • Annual report for 2025 published
202520 changesownership 13 · capital 1 · management 4 · accounts 1 · industry 1
  • Jarne Elleholm registered as owner (5%)
  • RA Capital Planetary Health Fund, L.P. registered as owner (15%)
  • Danmarks Eksport- og Investeringsfond registered as owner (10%)
  • SDBIO ApS registered as owner (5%)
  • STARFISH BIO ApS registered as owner (5%)
  • FormanBiotech Holding ApS registered as owner (5%)
  • Busiris Vermögensverwaltung GmbH is no longer registered as owner
  • March EXP I HoldCo D Limited is no longer registered as owner
  • FormanBiotech Holding ApS is no longer registered as owner
  • STARFISH BIO ApS is no longer registered as owner
  • SDBIO ApS is no longer registered as owner
  • Danmarks Eksport- og Investeringsfond is no longer registered as owner
  • Jarne Elleholm is no longer registered as owner
  • Share capital changed from 99,802 DKK to 137,980 DKK
  • Kyle Bjorn Teamey appointed board member
  • Lauri Johannes Reuter stepped down as board member
  • Sotirios Kampranis stepped down as board member
  • Simon Louis Théodore Armand Dusséaux stepped down as director
  • Annual report for 2024 published
  • Industry changed to Research and experimental development on natural sciences and engineering (721000)
202418 changesaccounts 1 · capital 1 · management 2 · ownership 14
  • Annual report for 2023 published
  • Share capital changed from 74,737 DKK to 99,802 DKK
  • Johan Bitsch Nielsen appointed board member
  • Bart Van Hooland stepped down as board member
  • FormanBiotech Holding ApS registered as owner (10%)
  • STARFISH BIO ApS registered as owner (10%)
  • SDBIO ApS registered as owner (10%)
  • Danmarks Eksport- og Investeringsfond registered as owner (5%)
  • Busiris Vermögensverwaltung GmbH registered as owner (5%)
  • March EXP I HoldCo D Limited registered as owner (5%)
  • BII Holdings A/S registered as owner (5%)
  • NFT.VC Fund I Ky registered as owner (5%)
  • BII Holdings A/S is no longer registered as owner
  • Busiris Vermögensverwaltung GmbH is no longer registered as owner
  • SDBIO ApS is no longer registered as owner
  • NFT.VC Fund I Ky is no longer registered as owner
  • FormanBiotech Holding ApS is no longer registered as owner
  • STARFISH BIO ApS is no longer registered as owner
20234 changesaddress 1 · accounts 1 · ownership 2
  • Moved to Islevdalvej 211, 2610 Rødovre
  • Annual report for 2022 published
  • BII Holdings A/S registered as owner (10%)
  • BioInnovation Institute Fonden is no longer registered as owner
202220 changescapital 1 · management 7 · ownership 11 · accounts 1
  • Share capital changed from 50,000 DKK to 74,737 DKK
  • Lauri Johannes Reuter appointed board member
  • Bart Van Hooland appointed board member
  • Busiris Vermögensverwaltung GmbH registered as owner (5%)
  • SDBIO ApS registered as owner (15%)
  • NFT.VC Fund I Ky registered as owner (5%)
  • BioInnovation Institute Fonden registered as owner (10%)
  • Jarne Elleholm registered as owner (10%)
  • FormanBiotech Holding ApS registered as owner (15%)
  • STARFISH BIO ApS registered as owner (15%)
  • Jarne Elleholm is no longer registered as owner
  • SDBIO ApS is no longer registered as owner
  • STARFISH BIO ApS is no longer registered as owner
  • FormanBiotech Holding ApS is no longer registered as owner
  • Annual report for 2021 published
  • Flemming Besenbacher appointed board member
  • Andreas Helmut Fibig appointed board member
  • Anne Françoise Véronique Cabotin appointed board member
  • Simon Louis Théodore Armand Dusséaux stepped down as board member
  • Victor Forman stepped down as board member
202115 changesownership 6 · management 8 · founded 1
  • Jarne Elleholm registered as owner (20%)
  • LEEWARD ApS is no longer registered as owner
  • Simon Louis Théodore Armand Dusséaux appointed director
  • Camilla Benedicte Kloss Fenneberg appointed ceo
  • Simon Louis Théodore Armand Dusséaux stepped down as ceo
  • Registered as EvodiaBio ApS
  • Jarne Elleholm appointed chair of the board
  • Sotirios Kampranis appointed board member
  • Simon Louis Théodore Armand Dusséaux appointed ceo
  • Simon Louis Théodore Armand Dusséaux appointed board member
  • Victor Forman appointed board member
  • LEEWARD ApS registered as owner (20%)
  • SDBIO ApS registered as owner (25%)
  • STARFISH BIO ApS registered as owner (25%)
  • FormanBiotech Holding ApS registered as owner (25%)

Related companies

Same industry in Rødovre

See all →

Same people in management

Largest in the industry

See all →

Source and updates

The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026.

View in CVRReport a correction